To investigate the use of ICG in fluorescence-guided laparoscopic lymph node biopsy (FGLLB) for abdominal lymph nodes affected by primary lymphoproliferative disease, aiming to improve diagnostic accuracy and patient outcomes.
Key Findings:
Fluorescence imaging with ICG may simplify the identification of lymph nodes during laparoscopic biopsy.
The study aims to evaluate the elective tropism of ICG towards lymph nodes in primary disease.
The ideal injection site, dosage, and timing of ICG administration are being assessed, with preliminary results indicating potential benefits.
Interpretation:
The use of ICG in FGLLB could enhance the accuracy and efficiency of lymph node biopsies in lymphoma diagnosis, potentially leading to better patient management.
Limitations:
The study is ongoing, and results are not yet available, which limits the ability to draw definitive conclusions.
Limited prior reports on ICG use in lymphatic tissue biopsy may affect the generalizability of findings.
Conclusion:
The FLABILY study aims to establish the efficacy of ICG in laparoscopic lymph node biopsy for lymphoma, potentially improving diagnostic outcomes and patient care.
by Marco Casaccia, Giovanni Alemanno, Paolo Prosperi, Graziano Ceccarelli, Stefano Olmi, Alberto Oldani, Mauro Santarelli, Roberta Tutino, Franco De Cian
